Is Creatine the Next Big Thing for Brain Health?
Creatine monohydrate is one of the most extensively studied sports supplements, with strong evidence for improving performance during repeated, high-intensity exercise and supporting resistance-training. . .
Creatine monohydrate is one of the most extensively studied sports supplements, with strong evidence for improving performance during repeated, high-intensity exercise and supporting resistance-training adaptations. Now, it is being promoted well beyond the gym, for memory, mood, focus, and protection againstcognitive decline. The interest is understandable, but the science does not yet support treating creatine as a provennootropicor brain-health supplement for healthy adults. The more accurate takeaway is that creatine is biologically plausible and promising in specific circumstances, but the human evidence remains early, mixed, and limited by small studies. A 2026 narrative review by Darren G. Candow and colleagues, “Creatine Supplementation and the Brain: Have We Put the Cart Before the Horse?”, offers a useful, measured assessment of this question. The authors conclude that although creatine may support brain function under certain forms of metabolicstress, much more research is needed before broad cognitive or brain-health claims are justified. The Biology Makes SenseThe adult brain represents roughly 2% of body mass but uses about 20% of the body’s energy at rest. Like muscle, it depends onATP, the cell’s immediate energy source, to support its work. Creatine helps buffer and regenerate ATP through the creatine-phosphocreatine system. In muscle, this system is especially important when energy demand rises rapidly during short, intense activity. In the brain, it may help cells manage fluctuating energy demands during situations such as sleep deprivation, mental fatigue, hypoxia, injury, or disease. Preclinical research also suggests that creatine could affect processes relevant to brain health, includingoxidative stress, neurotransmission, and cellularresilience. However, these mechanisms come largely from laboratory and animal research. They do not establish that creatine supplementation improves mood, memory, neuroprotection, or cognitive aging in people. That distinction matters: a plausible mechanism is a reason to study a supplement, not proof that it works. Where the Evidence Holds UpThe strongest signal so far appears to be in situations that place unusual demands on brain energy metabolism. Small studies suggest that creatine may help preserve some aspects of cognitive performance during sleep deprivation, mental fatigue, or hypoxia. A 2024meta-analysisof 16 randomized controlled trials involving 492 participants found small improvements in memory,attentiontime, and information-processing speed, but no statistically significant improvements in overallcognitionorexecutive function. The authors emphasized the need for larger, more robust trials. That evidence should be interpreted cautiously. The trials differed substantially in their participants, doses, study durations, cognitive tests, and research quality. A subsequent commentary also identified a methodological concern in the meta-analysis: multiple outcomes from the same participants may have been treated as independent observations, which can overstate the precision of the overall estimate. Earlier reviews reached a similarly cautious conclusion. Creatine may improveshort-term memoryand reasoning in some healthy participants, but findings for attention, reaction time, executive function, long-term memory, mental fatigue, and other outcomes have been inconsistent. Results also appear less reliable in young, healthy, well-rested people. Cognition Essential ReadsIn short, there is some evidence of potential benefit, but not enough to conclude that creatine reliably improves cognition in the average healthy adult. Potential Clinical UsesCreatine is also being studied in conditions associated with impaired brain energy metabolism, including major depressive disorder, mildtraumatic brain injury, Alzheimer’s disease, and post-COVIDfatigue. These are important research areas, but the evidence remains preliminary. Studies are generally small, short, exploratory, or designed primarily to evaluate feasibility and safety rather than to establish clinical efficacy. For example, a small pilot study in people with Alzheimer’s disease found that creatine supplementation was feasible and was associated with preliminary improvements in working memory and executive function. It was not designed to prove that creatine treats Alzheimer’s disease or slows cognitive decline. The Measurement ChallengeAn important limitation in this field is that researchers do not simply measure whether someone takes creatine and then assume that more reaches the brain. Brain creatine is commonly assessed with magnetic resonance spectroscopy, or MRS, a noninvasive imaging technique. MRS is valuable, but results can vary based on the brain region measured, scanner and acquisition settings, signal quality, data processing methods, and the way findings are reported. These methodological differences make it difficult to compare results across studies. Some studies have reported increases in brain creatine after supplementation, but the size of the increase varies considerably. Dose, duration, baseline creatine status, individual biology, transport into the brain, and the measurement method may all affect the response. This creates a key unanswered question: even if supplementation raises brain creatine levels, does that change translate into meaningful improvements in memory, attention, mood, daily functioning, or long-term cognitive health?We do not yet know. What We Still Do Not KnowSeveral major uncertainties remain:The optimal dose:Most studies have used 3 to 5 grams of creatine monohydrate daily, the same range commonly used in sportsnutrition. It is not known whether higher doses, longer use, or both are necessary to consistently alter brain creatine levels or cognitive outcomes. The optimal duration:Most cognitive studies have been short, often lasting days or weeks rather than years. There is little long-term evidence on whether creatine can prevent age-related cognitive decline or reducedementiarisk. Who benefits most:People with lower baseline dietary creatine intake, including vegetarians and vegans, may be plausible candidates for study. Older adults and people experiencing sleep loss, mental fatigue, or impaired energy metabolism may also be more likely to benefit than young, well-rested adults. Which outcomes matter:Researchers need adequately powered trials that measure outcomes people care about, not only laboratory cognitive tests, MRS findings, or mechanisticbiomarkers. A 2026 systematic review in older adults found limited but encouraging evidence for cognitive benefits, particularly in memory and attention. However, the review also concluded that higher-quality clinical trials are needed. Bottom LineCreatine monohydrate is a well-studied supplement for exercise performance, but it is not yet a proven brain-health supplement or nootropic. The most defensible claim is that creatine may modestly support aspects of cognitive performance when the brain is under metabolic stress, such as during sleep deprivation or fatigue. Its roles in healthy aging, mood, neurodegenerative disease, brain injury, and long-term cognitive protection remain promising but unproven. Creatine is generally well tolerated at customary doses in healthy adults, though people with kidney disease, chronic medical conditions, or questions about medications should speak with a clinician before using it. It can also raise blood creatinine levels, which may complicate interpretation of kidney-function testing. For now, the foundations of brain health remain less glamorous but better supported: sufficient sleep, regular physical activity, cardiovascular risk-factormanagement, social and intellectual engagement, and a nutrient-dense dietary pattern. Creatine may eventually earn a place alongside those habits, but the evidence is not there yet.